Recombinant Anti-M. tuberculosis 38kDa Antibody (HTM81) (CAT#: MRO-318-MZ)

1. Q 1: What are the primary research applications for the M. tuberculosis 38kDa antibody?

   A: The Recombinant Anti-M. tuberculosis 38kDa Antibody is predominantly used in the study of tuberculosis pathogenesis and immune response. It plays a critical role in identifying and characterizing the presence of the M. tuberculosis bacteria in various samples through techniques such as Western Blotting and ELISA. This aids researchers in understanding the bacterium's interactions with host cells, contributing to the development of diagnostic assays and potential therapeutic strategies.

2. Q 2: What diseases can be studied using this antibody?

   A: Primarily, this antibody facilitates the study of tuberculosis, particularly in terms of bacterial detection and immune system responses. It is instrumental in researching infection dynamics and host-pathogen interactions, which are critical for understanding tuberculosis pathogenesis and developing new diagnostic tools and vaccines.

3. Q 3: What role does the antibody play in protein interactions?

   A: Given its specificity, the antibody aids in elucidating protein-protein interactions involving the M. tuberculosis 38kDa antigen. These insights are valuable for understanding the molecular mechanisms of the bacterium's virulence and interaction with host immune factors, critical for advancing tuberculosis research.

View the frequently asked questions answered by Creative Biolabs Support.